Correlation Between Halozyme Therapeutics and Insmed

Can any of the company-specific risk be diversified away by investing in both Halozyme Therapeutics and Insmed at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Halozyme Therapeutics and Insmed into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Halozyme Therapeutics and Insmed Inc, you can compare the effects of market volatilities on Halozyme Therapeutics and Insmed and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Halozyme Therapeutics with a short position of Insmed. Check out your portfolio center. Please also check ongoing floating volatility patterns of Halozyme Therapeutics and Insmed.

Diversification Opportunities for Halozyme Therapeutics and Insmed

-0.04

Correlation Coefficient

Halozyme Therapeutics  Insmed

Good diversification

The 3 months correlation between Halozyme and Insmed is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding Halozyme Therapeutics and Insmed Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Insmed Inc and Halozyme Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Halozyme Therapeutics are associated (or correlated) with Insmed. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Insmed Inc has no effect on the direction of Halozyme Therapeutics i.e., Halozyme Therapeutics and Insmed go up and down completely randomly.

Pair Corralation between Halozyme Therapeutics and Insmed

Given the investment horizon of 90 days Halozyme Therapeutics is expected to generate 0.94 times more return on investment than Insmed. However, Halozyme Therapeutics is 1.07 times less risky than Insmed. It trades about 0.13 of its potential returns per unit of risk. Insmed Inc is currently generating about -0.11 per unit of risk. If you would invest  4,481  in Halozyme Therapeutics on September 20, 2024 and sell it today you would earn a total of  251.00  from holding Halozyme Therapeutics or generate 5.6% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Halozyme Therapeutics  vs.  Insmed Inc

Halozyme Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Halozyme Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's essential indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Insmed Inc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Insmed Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Insmed is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Halozyme Therapeutics and Insmed

The main advantage of trading using opposite Halozyme Therapeutics and Insmed positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Halozyme Therapeutics position performs unexpectedly, Insmed can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Insmed will offset losses from the drop in Insmed's long position.

The idea behind Halozyme Therapeutics and Insmed Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.